These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7849969)

  • 21. Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury.
    Cochran RP; Kunzelman KS; Vocelka CR; Akimoto H; Thomas R; Soltow LO; Spiess BD
    Ann Thorac Surg; 1997 May; 63(5):1326-32. PubMed ID: 9146323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of exchange transfusion with a red blood cell substitute on neonatal hemodynamics and organ blood flows.
    Breuninger HG; Rubenstein SD; Wolfson MR; Shaffer TH
    J Pediatr Surg; 1993 Feb; 28(2):144-50. PubMed ID: 8437066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in brain pH, PO2, PCO2, cerebral blood flow, and blood gases induced by a hyperosmolar oxyreplete hemosubstitute during cardiopulmonary bypass.
    Briceño JC; Runge TM; McGinity JW; Frisbee SE; Ottmers SE; Korvick DL; Calhoon JH; Miller OL; Hantler CB; Cruzen OG; Ybarra JR; Howelton RV; Mireles RZ; Benson CK
    ASAIO J; 1997; 43(1):13-8. PubMed ID: 9116347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A perfluorocarbon emulsion prime additive improves the electroencephalogram and cerebral blood flow at the initiation of cardiopulmonary bypass.
    Vocelka C; Spiess B; Soltow L; Thomas R; Gohra H; Akimoto H; Rothnie C; Kunzelman K; Verrier E; Cochran RP
    J Extra Corpor Technol; 1995 Mar; 27(1):6-10. PubMed ID: 10150757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume.
    Shapira OM; Aldea GS; Treanor PR; Chartrand RM; DeAndrade KM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Mar; 65(3):724-30. PubMed ID: 9527202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Roller Pump vs. Centrifugal Pump on Homologous Blood Transfusion in Pediatric Cardiac Surgery.
    Datt B; Nguyen MB; Plancher G; Ruzmetov M; O'Brien M; Kube A; Munro HM; Pourmoghadam KK; DeCampli WM
    J Extra Corpor Technol; 2017 Mar; 49(1):36-43. PubMed ID: 28298664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of On-Bypass Red Blood Cell Transfusion on Severe Postoperative Morbidity or Mortality in Children.
    Willems A; Datoussaid D; Tucci M; Sanchez Torres C; De Villé A; Fils JF; Van der Linden P
    Anesth Analg; 2016 Aug; 123(2):420-9. PubMed ID: 27331784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfluorocarbons as blood substitutes.
    Waxman K
    Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular applications of fluorocarbons: current status and future direction--a critical clinical appraisal.
    Ogilby JD
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1083-96. PubMed ID: 7849911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of perfluorocarbon emulsions for suppression of rejection reaction in kidney allotransplantation].
    Ilgiavishute IaS; Zhukauskas GIu; Dapshis KL; Onishchenko NA
    Khirurgiia (Mosk); 1993 May; (5):16-8. PubMed ID: 8089979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology.
    Lowe KC
    Vox Sang; 1991; 60(3):129-40. PubMed ID: 1862635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of ultrafiltration on end-cardiopulmonary bypass hematocrit during cardiac surgery.
    Mongero L; Stammers A; Tesdahl E; Stasko A; Weinstein S
    Perfusion; 2018 Jul; 33(5):367-374. PubMed ID: 29301459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in potassium concentration and haematocrit associated with cardiopulmonary bypass in paediatric cardiac surgery.
    Vohra HA; Adluri K; Willets R; Horsburgh A; Barron DJ; Brawn WJ
    Perfusion; 2007 Mar; 22(2):87-92. PubMed ID: 17708157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass.
    Holman WL; Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Pacifico AD
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):774-85. PubMed ID: 7564446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New transfusion strategies: red cell substitutes.
    Winslow RM
    Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preoperative autologous blood donation with cardiac surgery].
    Yoda M; Nonoyama M; Shimakura T; Morishita A; Takasaki T
    Kyobu Geka; 2003 Jun; 56(6):479-82. PubMed ID: 12795154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.